Treatments that may harm fertility informed consent requirement provision
Minnesota bill requires healthcare providers to disclose fertility impacts and preservation options before administering treatments that may impair reproductive capacity.
Minnesota bill requires healthcare providers to disclose fertility impacts and preservation options before administering treatments that may impair reproductive capacity.
SF 3566 requires healthcare providers to obtain informed consent from patients before administering treatments that may harm fertility. The bill mandates that providers disclose potential fertility impacts and discuss reproductive preservation options before treatment begins. This applies to medical interventions where fertility impairment is a known or reasonably foreseeable side effect.
Cancer treatments, hormone therapies, and certain surgical procedures can significantly reduce or eliminate reproductive capacity, often affecting younger patients with decades of reproductive life ahead. Without explicit disclosure and discussion, patients may not understand permanent consequences or know that fertility preservation options (like egg/sperm banking) exist and may have time-sensitive availability. This addresses a documented gap where patients report insufficient counseling about reproductive impacts before undergoing such treatments.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.